MRI ASSESSMENT OF TUMOR SIZE IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS TREATED WITH DENDRITIC CELL IMMUNOTHERAPY

被引：0
|
作者：
Cuccarini, V. [1 ]
Schettino, C. [2 ,3 ]
Acquino, D. [4 ]
Scotti, A. [4 ]
Cuppini, L. [2 ]
Finocchiaro, G. [2 ]
Bruzzone, M. [4 ]
Eoli, M. [5 ]
机构：
[1] Ist Neurol Besta, Unit Neuroradiol, Milan, Italy
[2] Ist Neurol Besta, Uniti Mol Neurooncol, Milan, Italy
[3] Univ Naples 2, Naples, Italy
[4] Ist Neurol Besta, Uniti Neuroradiol, Milan, Italy
[5] Ist Neurol Besta, Unit Mol Neurooncol, Milan, Italy
来源：
NEURO-ONCOLOGY | 2014年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P02.01
引用
收藏
页数：1
相关论文
共 50 条
  • [21] LONG TERM REMISSION/SURVIVAL OVER 8 YEARS IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM) TREATED WITH ICT-107 DENDRITIC CELL-BASED IMMUNOTHERAPY (PHASE I)
    Phuphanich, S.
    Wheeler, C.
    Rudnick, J.
    Hu, J.
    Mazer, M.
    Nuno, M.
    Sanchez, C.
    Chu, R.
    Black, K.
    Yu, J.
    NEURO-ONCOLOGY, 2016, 18 : 5 - 5
  • [22] Autologous Tumor Lysate-pulsed Dendritic Cell Immunotherapy for Pediatric Patients with Newly Diagnosed or Recurrent High-grade Gliomas
    Lasky, Joseph L., III
    Panosyan, Eduard H.
    Plant, Ashley
    Davidson, Tom
    Yong, William H.
    Prins, Robert M.
    Liau, Linda M.
    Moore, Theodore B.
    ANTICANCER RESEARCH, 2013, 33 (05) : 2047 - 2056
  • [23] MRI changes in patients with newly diagnosed glioblastoma treated as part a Phase II trial with bavituximab, radiation, and temozolomide
    Ly, Ina
    Cardona, Jonathan
    Beers, Andrew
    Chang, Ken
    Brown, James
    Reardon, David
    Arrillaga-Romany, Isabel
    Dietrich, Jorg
    Forst, Deborah
    Lee, Eudocia
    Jordan, Justin
    Nayak, Lakshmi
    Wen, Patrick
    Batchelor, Tracy
    Curry, William
    Kalpathy-Cramer, Jayashree
    Gerstner, Elizabeth
    NEUROLOGY, 2019, 92 (15)
  • [24] MRI CHANGES IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS TREATED AS PART OF A PHASE II TRIAL WITH BAVITUXIMAB, RADIATION, AND TEMOZOLOMIDE
    Ly, Ina
    Cardona, Jonathan
    Beers, Andrew
    Chang, Ken
    Brown, James
    Reardon, David
    Arrillaga-Romany, Isabel
    Dietrich, Jorg
    Forst, Deborah
    Lee, Eudocia
    Jordan, Justin
    Nayak, Lakshmi
    Wen, Patrick
    Batchelor, Tracy
    Kalpathy-Cramer, Jayashree
    Gerstner, Elizabeth
    NEURO-ONCOLOGY, 2018, 20 : 191 - 191
  • [25] ALLOGENEIC TUMOR LYSATE / AUTOLOGOUS DENDRITIC CELL VACCINES IN NEWLY DIAGNOSED GLIOBLASTOMA: CLINICAL TRIAL MC1272
    Parney, Ian F.
    Gustafson, Michael P.
    Peterson, Timothy
    Steinmetz, Susan M.
    Bulur, Peggy
    Dietz, Allan B.
    NEURO-ONCOLOGY, 2016, 18 : 24 - 25
  • [26] Correlation of survival with tumor antigen expression in patients with newly diagnosed glioblastoma receiving a multi-epitope pulsed dendritic cell vaccine.
    Phuphanich, Surasak
    Wheeler, Christopher Jay
    Rudnick, Jeremy
    Mazer, Mia
    Wang, Hong Qiang
    Nuno, Miriam
    Richardson, Jaime
    Fan, Xuemo
    Ji, Jianfei
    Chu, Ray M.
    Bender, James
    Hawkins, Elma S.
    Patil, Chirag
    Black, Keith L.
    Yu, John
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [27] ACRIN 6684: Assessment of Tumor Hypoxia in Newly Diagnosed Glioblastoma Using 18F-FMISO PET and MRI
    Gerstner, Elizabeth R.
    Zhang, Zheng
    Fink, James R.
    Muzi, Mark
    Hanna, Lucy
    Greco, Erin
    Prah, Melissa
    Schmainda, Kathleen M.
    Mintz, Akiva
    Kostakoglu, Lale
    Eikman, Edward A.
    Ellingson, Benjamin M.
    Ratai, Eva-Maria
    Sorensen, A. Gregory
    Barboriak, Daniel P.
    Mankoff, David A.
    CLINICAL CANCER RESEARCH, 2016, 22 (20) : 5079 - 5086
  • [28] Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma
    Phuphanich, Surasak
    Wheeler, Christopher J.
    Rudnick, Jeremy D.
    Mazer, Mia
    Wang, HongQian
    Nuno, Miriam A.
    Richardson, Jaime E.
    Fan, Xuemo
    Ji, Jianfei
    Chu, Ray M.
    Bender, James G.
    Hawkins, Elma S.
    Patil, Chirag G.
    Black, Keith L.
    Yu, John S.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2013, 62 (01) : 125 - 135
  • [29] Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma
    Surasak Phuphanich
    Christopher J. Wheeler
    Jeremy D. Rudnick
    Mia Mazer
    HongQian Wang
    Miriam A. Nuño
    Jaime E. Richardson
    Xuemo Fan
    Jianfei Ji
    Ray M. Chu
    James G. Bender
    Elma S. Hawkins
    Chirag G. Patil
    Keith L. Black
    John S. Yu
    Cancer Immunology, Immunotherapy, 2013, 62 : 125 - 135
  • [30] Treatment for Patients With Newly Diagnosed Glioblastoma
    Chamberlain, Marc C.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (21): : 2348 - 2348
12345